Ketogenic Diet for New-Onset Absence Epilepsy

clinical trial

Details

Instance of: clinical trial
Start time: 1 May 2020
End time: 1 May 2023
Country: United States
Main subject: ketogenic diet, epilepsy
clinical trial phase: phase III clinical trial
maximum age: 12
minimum age: 3
number of participants: 40
research intervention: lamotrigine, valproic acid, ethosuximide
sponsor: Johns Hopkins University
study type: interventional study
title: A Prospective, Case-control Evaluation of Ketogenic Dietary Therapy for New-onset Childhood Absence Epilepsy

Nothing in the MetaHistoryBook collection references this item yet.